Literature DB >> 18270834

The effect of processing on liver biopsy core size.

Thomas R Riley1, Francesca M Ruggiero.   

Abstract

OBJECTIVES: Liver biopsy is a valuable clinical tool, but for the interpretation to be meaningful a certain core size should be obtained. This study examines the changes the liver biopsy core undergoes during processing steps.
METHODS: A total of 61 consecutive percutaneous liver biopsies were obtained between November 2004 and April 2005. The needle type utilized was the 16-gauge automatic tru-cut. A measurement was made while each liver biopsy core specimen resided in the cartridge, then a measurement was made with the core placed on the tray, and a final measurement was made after the pathologist received the formalin-fixed specimen.
RESULTS: The mean size of the biopsy core in the cartridge measured 15 +/- 2 mm, compared to a mean size on the tray of 19.6 +/- 3.5 mm, and a mean size after fixation of 18.3 mm. All mean sizes were statistically different from one another. The compressive effect of the cartridge was 23%. The shrinkage effect of formalin fixation was 7%.
CONCLUSIONS: The liver biopsy core size changes significantly through the processing steps. It is imperative that the operator is aware of these changes so that appropriate decisions are made. As an example, if the operator underestimates the core size when measured in the cartridge, a second pass may be completed when in fact adequate tissue had been obtained on the first pass.

Entities:  

Mesh:

Year:  2008        PMID: 18270834     DOI: 10.1007/s10620-007-0181-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Liver biopsy size matters in chronic hepatitis: bigger is better.

Authors:  Peter J Scheuer
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

3.  Predictors of pain medication use after percutaneous liver biopsy.

Authors:  Thomas R Riley
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

4.  A 21-year experience with major hemorrhage after percutaneous liver biopsy.

Authors:  D B McGill; J Rakela; A R Zinsmeister; B J Ott
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

5.  The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy.

Authors:  K D Lindor; C Bru; R A Jorgensen; J Rakela; J M Bordas; J B Gross; J Rodes; D B McGill; C C Reading; E M James; J W Charboneau; J Ludwig; K P Batts; A R Zinsmeister
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

6.  Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies.

Authors:  M Kage; K Shimamatu; E Nakashima; M Kojiro; O Inoue; M Yano
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

7.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.

Authors:  Guido Colloredo; Maria Guido; Aurelio Sonzogni; Gioacchino Leandro
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

8.  The normal adult human liver biopsy: a quantitative reference standard.

Authors:  A R Crawford; X Z Lin; J M Crawford
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

9.  Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.

Authors:  K Kaserer; R Fiedler; P Steindl; C H Müller; F Wrba; P Ferenci
Journal:  Histopathology       Date:  1998-05       Impact factor: 5.087

10.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  1 in total

1.  Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.

Authors:  Gamal Shiha; Alaa Ibrahim; Ahmed Helmy; Shiv Kumar Sarin; Masao Omata; Ashish Kumar; David Bernstien; Hitushi Maruyama; Vivek Saraswat; Yogesh Chawla; Saeed Hamid; Zaigham Abbas; Pierre Bedossa; Puja Sakhuja; Mamun Elmahatab; Seng Gee Lim; Laurentius Lesmana; Jose Sollano; Ji-Dong Jia; Bahaa Abbas; Ashraf Omar; Barjesh Sharma; Diana Payawal; Ahmed Abdallah; Abdelhamid Serwah; Abdelkhalek Hamed; Aly Elsayed; Amany AbdelMaqsod; Tarek Hassanein; Ahmed Ihab; Hamsik GHaziuan; Nizar Zein; Manoj Kumar
Journal:  Hepatol Int       Date:  2016-10-06       Impact factor: 6.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.